Utah Medical Products Inc
UTMD· Nasdaq
Released Feb 1, 2022, after the close
10-K filed Mar 25, 2022, 84 days after period end · 0001811884-22-000004
| Metric | Q4 2021 | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $12.91M | $12.01M | $11.83M | $9.76M |
| Net Income | $4.13M | $3.41M | $4.36M | $3.39M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.13 |
| $0.94 |
| $1.17 |
| $0.91 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.